Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Similar articles for PubMed (Select 23568447)

1.

Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.

Park J, Park S, Song C, Hong JH, Kim CS, Ahn H.

World J Urol. 2014 Feb;32(1):157-63. doi: 10.1007/s00345-013-1073-8. Epub 2013 Apr 9.

PMID:
23568447
2.

International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.

Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF.

BJU Int. 2012 Sep;110(5):674-81. doi: 10.1111/j.1464-410X.2012.10930.x. Epub 2012 Feb 20.

PMID:
22348322
3.

The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.

Park J, Ha SH, Min GE, Song C, Hong B, Hong JH, Kim CS, Ahn H.

J Urol. 2009 Sep;182(3):894-9. doi: 10.1016/j.juro.2009.05.040. Epub 2009 Jul 17.

PMID:
19616243
4.

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.

Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.

Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

PMID:
22521771
5.

[Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma].

Bruzzi M, Le Goux C, Pignot G, Amsellem-Ouazana D, Vieillefond A, Patard JJ, Zerbib M.

Prog Urol. 2014 Jul;24(9):556-62. doi: 10.1016/j.purol.2013.12.005. Epub 2014 Jan 21. French.

PMID:
24975790
6.

Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.

Park J, Habuchi T, Arai Y, Ohyama C, Inoue T, Hatakeyama S, Jeon SS, Kwon GY, Kwak C, Moon KC, Kim CS, Ahn H.

J Urol. 2014 Oct;192(4):1064-71. doi: 10.1016/j.juro.2014.04.001. Epub 2014 Apr 13.

PMID:
24735938
7.

Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma.

Cho KS, Cho NH, Park SY, Cho SY, Choi YD, Chung BH, Yang SC, Hong SJ.

J Korean Med Sci. 2008 Jun;23(3):434-8. doi: 10.3346/jkms.2008.23.3.434.

8.

The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.

Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G.

Eur Urol. 2010 Oct;58(4):574-80. doi: 10.1016/j.eururo.2010.07.003. Epub 2010 Jul 9.

9.

The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.

Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY.

J Urol. 2007 Aug;178(2):446-50, dicussion 450. Epub 2007 Jun 11.

PMID:
17561129
10.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

PMID:
22177329
11.

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.

Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021. Epub 2012 Jan 23.

PMID:
22284969
12.

Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.

Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C.

Eur Urol. 2012 Aug;62(2):224-31. doi: 10.1016/j.eururo.2012.01.019. Epub 2012 Jan 24.

PMID:
22285763
13.

Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.

Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.

Urol Oncol. 2014 Jul;32(5):619-24. doi: 10.1016/j.urolonc.2013.11.006. Epub 2014 Feb 2.

PMID:
24495448
14.

The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.

Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G, Ruffion A, Cornu JN, Hurel S, Valeri A, Roumiguie M, Polguer T, Hoarau N, Mérigot de Treigny O, Xylinas E, Matte A, Droupy S, Fais PO, Descazeaud A, Colin P; MD for the French Collaborative National Database on UUT-UC.

World J Urol. 2013 Feb;31(1):69-76. doi: 10.1007/s00345-012-0959-1. Epub 2012 Oct 16.

PMID:
23070533
15.

Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.

Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A, Kapoor A, Black P, Lacombe L, Tanguay S, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Izawa JI.

Urol Oncol. 2013 Oct;31(7):1161-5. doi: 10.1016/j.urolonc.2011.12.004. Epub 2013 Feb 13.

PMID:
23415596
16.

No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.

Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G.

World J Urol. 2011 Aug;29(4):465-72. doi: 10.1007/s00345-011-0705-0. Epub 2011 Jun 1.

PMID:
21630120
17.

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.

Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.

Urol Oncol. 2013 Nov;31(8):1725-30. doi: 10.1016/j.urolonc.2012.05.008. Epub 2012 Nov 8.

PMID:
23141922
18.

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M; French Collaborative National Database on UUT-UC.

Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049. Epub 2011 Jun 7.

PMID:
21665356
19.

Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.

Masson-Lecomte A, Colin P, Bozzini G, Nison L, de La Taille A, Comperat E, Zerbib M, Rozet F, Cathelineau X, Valeri A, Ruffion A, Guy L, Droupy S, Cussenot O, Rouprêt M.

World J Urol. 2014 Apr;32(2):531-7. doi: 10.1007/s00345-013-1141-0. Epub 2013 Aug 2.

PMID:
23907662
20.

Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.

Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.

Urol Oncol. 2013 Nov;31(8):1643-9. doi: 10.1016/j.urolonc.2012.04.014. Epub 2012 May 15.

PMID:
22591745
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk